Skip to main content
Coronavirus prevention: Regeneron’s antibody cocktail 'REGN-COV2' enters phase 3 human trials - Times Now 08-Jul-2020
Coronavirus prevention: Regeneron’s antibody cocktail 'REGN-COV2' enters phase 3 human trials - Times Now
Regeneron Pharmaceuticals' experimental double-antibody cocktail, REGN-COV2, designed to prevent and treat COVID-19 is entering phase 3 human trials.
More...